Recently, an increasing number of studies have confirmed that ERRα is a key regulator of metabolism in obesity-related tumors, such as breast cancer [23], prostate cancer [24], and EC [25]. The gene discussed is ESRRA; the disease is obesity due to melanocortin 4 receptor deficiency.